30 Oct 2020

Disposals of own shares

Read More
29 Oct 2020

UCB Presents Nine Abstracts at EADV 2020, Showcasing Ongoing Commitment to Dermatology

Read More
23 Oct 2020

Disposals of own shares

Read More
22 Oct 2020

UCB’s anti-epileptic drug VIMPAT[®] (lacosamide) receives EU CHMP positive opinion for primary generalised tonic-clonic seizures

Read More
16 Oct 2020

UCB FURTHER INVESTS IN UK OPERATIONS WITH AGREEMENT TO ACQUIRE A NEW LEADING-EDGE CAMPUS

Read More
9 Oct 2020

Disposals of own shares

Read More
2 Oct 2020

Disposals of own shares

Read More
2 Oct 2020

Changes in UCB's Board of Directors

Read More
25 Sep 2020

Disposals of own shares

Read More
22 Sep 2020

UCB Achieves Important Regulatory Milestone for Bimekizumab

Read More
Subscribe to